Neuroacanthocytosis update

Brain and Nerve

Volumn 60, Issue 6, 2008, Pages 635-641

  Ichiba, Mio ^a   Nakamura, Masayuki ^a   Sano, Akira ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Chorea acanthocytosis; Huntington's disease like 2; McLeod syndrome; Neuroacanthocytosis; Pantothenate kinase associated neurodegeneration

Indexed keywords

ABETALIPOPROTEINEMIA; ALLELE; CHOREA; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HARP SYNDROME; HUMAN; HUNTINGTON DISEASE LIKE SYNDROME; HYPOBETALIPOPROTEINEMIA; MALABSORPTION; MCLEOD SYNDROME; MOTOR DYSFUNCTION; NERVE DEGENERATION; NEUROACANTHOCYTOSIS; NEUROLOGIC DISEASE; PANTOTHENATE KINASE ASSOCIATED NEURODEGENERATION; REVIEW;

ABETALIPOPROTEINEMIA; ANIMALS; BASAL GANGLIA; CHOREA; HUMANS; HUNTINGTON DISEASE; HYPOBETALIPOPROTEINEMIAS; HYPOLIPOPROTEINEMIAS; NEUROACANTHOCYTOSIS; PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION; POLYMETHYL METHACRYLATE; RETINITIS PIGMENTOSA;

EID: 46049120802     PISSN: 18816096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Rovito DA, Pirone FJ: Acanthrocytosis associated with schizophrenia. Am J Psychiatry 120: 182-185, 1963
2. Levine IM, Estes JW, Looney JM: Hereditary neurological disease with acanthocytosis. A new syndrome. Arch Neurol 19: 403-409, 1968
3. Critchley EM, Clark DB, Wikler A: Acanthocytosis and neurological disorder without betalipoproteinemia. Arch Neurol 18: 134-140, 1968
4. Hardie RJ, Pullon HW, Harding AE, Owen JS, Pires M, et al: Neuroacanthocytosis. A clinical, haematological and pathological study of 19 cases. Brain 114: 13-49, 1991
5. Walker RH, Liu Q, Ichiba M, Muroya S, Nakamura M, et al: Self-mutilation in chorea-acanthocytosis: Manifestation of movement disorder or psychopathology? Mov Disord 21: 2268-2269, 2006
6. Danek A, Jung HH, Melone MA, Rampoldi L, Broccoli V, et al: Neuroacanthocytosis: new developments in a neglected group of dementing disorders. J Neurol Sci 229-230: 171-186, 2005
7. Kageyama Y, Matsumoto K, Ichikawa K, Ueno S, Ichiba M, et al: A new phenotype of chorea-acanthocytosis with dilated cardiomyopathy and myopathy. Mov Disord 22: 1669-1670, 2007
8. Ichiba M, Nakamura M, Kusumoto A, Mizuno E, Kurano Y, et al: Clinical and molecular genetic assessment of a chorea-acanthocytosis pedigree. J Neurol Sci 263: 124-132, 2007
9. Ueno S, Maruki Y, Nakamura M, Tomemori Y, Kamae K, et al: The gene encoding a newly discovered protein, chorein, is mutated in chorea- acanthocytosis. Nat Genet 28: 121-122, 2001
10. Rampoldi L, Dobson-Stone C, Rubio JP, Danek A, Chalmers RM, et al: A conserved sorting-associated protein is mutant in chorea-acanthocytosis. Nat Genet 28: 119-120, 2001
11. Velayos-Baeza A, Vettori A, Copley RR, Dobson-Stone C, Monaco AP: Analysis of the human VPS13 gene family. Genomics 84: 536-549, 2004
12. Dobson-Stone C, Danek A, Rampoldi L, Hardie RJ, Chalmers RM, et al: Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis. Eur J Hum Genet 10: 773-781, 2002
13. Tomemori Y, Ichiba M, Kusumoto A, Mizuno E, Sato D, et al: A gene-targeted mouse model for chorea-acanthocytosis. J Neurochem 92: 759-766, 2005
14. Mizuno E, Nakamura M, Agemura A, Kusumoto A, Ichiba M, el al: Brain-specific transcript variants of 5′ and 3' ends of mouse VPS13A and VPS13C. Biochem Biophys Res Commun 353: 902-907, 2007
15. Kurano Y, Nakamura M, Ichiba M, Matsuda M, Mizuno E, et al: In vivo distribution and localization of chorein. Biochem Biophys Res Commun 353: 431-435, 2007
16. Kurano Y, Nakamura M, Ichiba M, Matsuda M, Mizuno E, et al: Chorein deficiency leads to upregulation of gephyrin and GABA(A) receptor. Biochem Biophys Res Commun 351: 438-442, 2006
17. Allen FH, Krabbe SMR, Corcoran PA: A new phenotype (McLeod) in the Kell blood-group system Vox Sang 6: 555-560, 1961
18. Jung HH: Update on McLeod Syndrome. In: Neuroacanthocytosis Syndromes II,Walker RH, Saiki S, Danek A (eds), Springer, London, 2007, pp53-58
19. Ho M, Chelly J, Carter N, Danek A, Crocker P, et al: Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein. Cell 77: 869-880, 1994
20. Danek A, Rubio JP, Rampoldi L, HoM, Dobson-Stone C, et al: McLeod neuroacanthocytosis: genotype and phenotype. Ann Neurol 50: 755-764, 2001
21. Nicholl DJ, Sutton I, Dotti MT, Supple SG, Danek A, et al: White matter abnormalities on MRI in neuroacanthocytosis. J Neurol Neurosurg Psychiatry 75: 1200-1201, 2004
22. Jung HH, Hergersberg M, Kneifel S, Alkadhi H, Schiess R, et al: McLeod syndrome: a novel mutation, predominant psychiatric manifestations, and distinct striatal imaging findings. Ann Neurol 49: 384-392, 2001
23. Stanfield GM, Horvitz HR: The ced-8 gene controls the timing of programmed cell deaths in C. elegans. Molec. Cell 5: 423-433, 2000
24. Margolis RL, Rudnicki DD: Huntington's Disease-Like 2. In: Neuroacanthocytosis Syndromes II, Walker RH, Saiki S, Danek A (eds), Springer, London, 2007, pp59 74
25. Walker RH, Morgello S, Davidoff-Feldman B, Melnick A, Walsh MJ, et al: Autosomal dominant chorea-acanthocytosis with polyglutamine-containing neuronal inclusions. Neurology 58: 1031-1037, 2002
26. Holmes SE, O'Hearn E, Rosenblatt A, Callahan C, Hwang HS, et al: A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2. Nat Genet 29: 377-378, 2001
27. Margolis RL, Holmes SE, Rosenblatt A, Gourley L, O'Hearn E, et al: Greenstein P Huntington's disease-like 2 (HDL2) in North America and Japan. Ann Neurol 56: 670-674, 2004
28. Margolis RL, O'Hearn E, Rosenblatt A, Willour V, Holmes SE, et al: A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion. Ann Neurol 50: 373-380, 2001
29. Trottier Y, Lutz Y, Stevanin G, Imbert G, Devys D, et al: Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature 378: 403-406, 1995
30. Nishi M, Hashimoto K, Kuriyama K Komazaki S Kano M, et al: Motor discoordination in mutant mice lacking junctophilin type 3. Biochem Biophys Res Commun 292: 318-324, 2002
31. Moriguchi S, Nishi M, Komazaki S, Sakagami H, Miyazaki T, et al: Functional uncoupling between Ca2+ release and after hyperpolarization in mutant hippocampal neurons lacking junctophilins. Proc Natl Acad Sci U S A 103: 10811-10816, 2006
32. Taylor T D, Litt M, Kramer P, Pandolfo M, Angelini L, et al: Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13. Nature Genet 14: 479-481, 1996
33. Zhou B, Westaway SK, Levinson B, Johnson MA, Gitschier J, et al: A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 28: 345-349, 2001
34. Pellecchia MT, Valente EM, Cif L, Salvi S, Albanese A, et al: The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration. Neurology 64: 1810-1812, 2005
35. Ching KHL, Westaway SK, Gitschier J, Higgins JJ, Hayflick SJ: HARP syndrome is allelic with pantothenate kinase-associated neurodegeneration. Neurology 58: 1673-1674, 2002
36. Kuo YM, Duncan JL, Westaway SK, Yang H, Nune G, et al: Deficiency of pantothenate kinase 2 (Pank2) in mice leads to retinal degeneration and azoospermia. Hum Molec Genet 14: 49-57, 2005
37. Bassen FA, Kornzweig AL: Malformation of the erythrocytes in a case of atypical retinitis pigmentosa. Blood 5: 381-387, 1950
38. Sharp D, Blinderman L, Combs KA, Kienzle B, Ricci B, et al: Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia. Nature 365: 65-69, 1993
39. Muller DP, Lloyd JK, Bird AC: Long-term management of abetalipoproteinaemia. Possible role for vitamin E. Arch Dis Child 52: 209-214, 1977
40. Azizi E, Zaidman JL, Eshchar J, Szeinberg A: Abetalipoproteinemia treated with parenteral and oral vitamins A and E, and with medium chain triglycerides. Acta Paediatr Scand 67: 796-801, 1978
41. Muller DP, Lloyd JK: Effect of large oral doses of vitamin E on the neurological sequelae of patients with abetalipoproteinemia. Ann N Y Acad Sci 393: 133-144, 1982
42. Raabe M, Flynn LM, Zlot CH, Wong JS, Véniant MM, et al: Knockout of the abetalipoproteinemia gene in mice: reduced lipoprotein secretion in heterozygotes and embryonic lethality in homozygotes. Proc Natl Acad Sci U S A 95: 8686-8691, 1998
43. Pulai JI, Neuman RJ, Groenewegen AW, Wu J, Schonfeld G: Genetic heterogeneity in familial hypobetalipoproteinemia: linkage and non- linkage to the apoB gene in Caucasian families. Am J Med Genet 76: 79-86, 2003
44. Yuan B, Neuman R, Duan SH, Weber JL, Kwok PY, et al: Linkage of a gene for familial hypobetalipoproteinemia to chromosome 3p21.1-22. Am J Hum Genet 66: 1699-1704, 2000